Paradice Investment Management LLC Sells 20,857 Shares of Envista Holdings Corporation $NVST

Paradice Investment Management LLC lessened its position in shares of Envista Holdings Corporation (NYSE:NVST) by 1.1% in the second quarter, according to its most recent filing with the SEC. The firm owned 1,826,308 shares of the company’s stock after selling 20,857 shares during the quarter. Envista makes up approximately 7.2% of Paradice Investment Management LLC’s investment portfolio, making the stock its 3rd largest holding. Paradice Investment Management LLC owned approximately 1.10% of Envista worth $35,686,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Assetmark Inc. increased its position in shares of Envista by 9.5% during the first quarter. Assetmark Inc. now owns 43,388 shares of the company’s stock worth $749,000 after buying an additional 3,764 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Envista by 6.3% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 44,709 shares of the company’s stock valued at $772,000 after acquiring an additional 2,652 shares during the last quarter. XTX Topco Ltd bought a new stake in Envista during the first quarter valued at $779,000. Vestcor Inc acquired a new stake in Envista during the 1st quarter worth about $211,000. Finally, US Bancorp DE raised its position in shares of Envista by 22.7% in the 1st quarter. US Bancorp DE now owns 26,898 shares of the company’s stock worth $464,000 after acquiring an additional 4,979 shares in the last quarter.

Envista Stock Performance

Shares of NVST stock opened at $20.99 on Friday. The firm has a market capitalization of $3.45 billion, a PE ratio of 65.61, a price-to-earnings-growth ratio of 1.09 and a beta of 1.05. The firm has a fifty day simple moving average of $20.10 and a two-hundred day simple moving average of $19.87. The company has a current ratio of 2.44, a quick ratio of 2.08 and a debt-to-equity ratio of 0.46. Envista Holdings Corporation has a 12 month low of $14.22 and a 12 month high of $22.68.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, October 29th. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. The firm had revenue of $669.90 million for the quarter, compared to analyst estimates of $639.49 million. Envista had a net margin of 2.11% and a return on equity of 4.84%. The business’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period last year, the firm earned $0.12 earnings per share. Analysts forecast that Envista Holdings Corporation will post 1 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms recently commented on NVST. Morgan Stanley raised their target price on Envista from $16.00 to $17.00 and gave the stock an “equal weight” rating in a research note on Friday, August 1st. Stifel Nicolaus set a $25.00 price objective on shares of Envista in a research note on Thursday, October 30th. Evercore ISI reissued an “outperform” rating on shares of Envista in a research note on Friday, October 31st. Piper Sandler raised their price target on shares of Envista from $17.00 to $19.00 and gave the stock a “neutral” rating in a report on Friday, August 1st. Finally, Robert W. Baird set a $27.00 price objective on shares of Envista in a report on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, Envista has an average rating of “Hold” and an average target price of $21.33.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.